REBECCA Real-world Early BrEast CanCer mAnagement - REBECCA
Study identifier:D0817R00068
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Will Be Recruiting
Official Title
REBECCA Real-world Early BrEast CanCer mAnagement REBECCA. a French national multicentric real-world study of early breast cancer patients
Medical condition
Breast Cancer
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Estimated Enrollment
126
Study type
Observational
Age
18 Years - n/a
Date
Study Start Date: 31 Jan 2025
Estimated Primary Completion Date: 31 Jan 2028
Estimated Study Completion Date: 31 Jan 2028
Study design
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2024 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
